Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Harvard Bioscience (HBIO) Change in Inventory (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Change in Inventory for 16 consecutive years, with -$663000.0 as the latest value for Q4 2025.

Quarterly Change in Inventory rose 71.81% to -$663000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.9 million through Dec 2025, down 4704.69% year-over-year, with the annual reading at -$2.9 million for FY2025, 4704.69% down from the prior year.
Change in Inventory for Q4 2025 was -$663000.0 at Harvard Bioscience, down from -$637000.0 in the prior quarter.
The five-year high for Change in Inventory was $1.9 million in Q2 2021, with the low at -$2.4 million in Q4 2024.
Average Change in Inventory over 5 years is $60100.0, with a median of $258500.0 recorded in 2023.
The sharpest move saw Change in Inventory skyrocketed 5033.33% in 2021, then tumbled 253.61% in 2022.
Over 5 years, Change in Inventory stood at $1.8 million in 2021, then tumbled by 132.05% to -$581000.0 in 2022, then crashed by 132.53% to -$1.4 million in 2023, then crashed by 74.09% to -$2.4 million in 2024, then surged by 71.81% to -$663000.0 in 2025.
According to Business Quant data, Change in Inventory over the past three periods came in at -$663000.0, -$637000.0, and -$977000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.